RASHID MUSLEM ALMASHRAFI

Mr. RASHID MUSLEM ALMASHRAFI


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2026 in Membranes
Verified
Journal Article
Open access
PDF file
AAAmal AlSaadi
Amal AlSaadi
IAIsmail Al-Yahmadi
Ismail Al-Yahmadi
Sharif ZeinSharif Zein
Sharif Zein
Rajamohan NatarajanRajamohan Natarajan
Rajamohan Natarajan
IBIntisar Al Busaidi
Intisar Al Busaidi
RARASHID MUSLEM ALMASHRAFI
RASHID MUSLEM ALMASHRAFI
Naturally Occurring Radioactive Materials (NORMs) in industrial wastewater present significant environmental and public health challenges due to their persistence and radiotoxic effects. This comprehensive review analyzes 108 peer-reviewed publications from 2014 to 2025 on NORM treatment technologies for industrial wastewater. While previous reviews have focused on individual treatment methods or laboratory-scale studies, this work provides comparative performance analysis across multiple technologies under realistic industrial conditions, including high-salinity environments and competing ions. We emphasize membrane filtration, electrocoagulation (EC), ion exchange, and advanced oxidation processes, evaluating both their economic feasibility and environmental sustainability for practical industrial implementation. The review discusses the advantages and limitations of existing techniques, highlighting the need for integrated strategies that combine physical, chemical, and biological processes for enhanced remediation. Hybrid systems combining multiple technologies outperform individual approaches by 15–25% in removal efficiency. These advances are critical for ensuring safe water reuse and protecting water resources from radioactive contamination. Additionally, regulatory frameworks governing NORM management are examined, underscoring the importance of standardized disposal and treatment protocols. The review concludes by identifying research gaps and future directions. Priority areas include developing standardized treatment protocols and strengthening academia–industry collaboration to achieve scalable solutions aligned with UN Sustainable Development Goal 6.